Dilatrend 12
Dilatrend 12 is a medicine authorised by Swissmedic under authorisation number 53162. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 August 1995 and the authorisation is valid without a time limit. ATC code C07AG02 places the medicine in the group Beta blocking agents.
| Authorisation number | 53162 |
|---|---|
| Name | Dilatrend 12 |
| Full name | Dilatrend 12,5 mg, Tabletten |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C07AG02 |
| First authorisation | 29 August 1995 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dilatrend 12,5 mg, Tabletten | B | 29 August 1995 |
| 2 | Dilatrend 25 mg, Tabletten | B | 29 August 1995 |
| 4 | Dilatrend 6,25 mg, Tabletten | B | 24 July 1998 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 10 | 30 | Tablette(n) | C07AG02 | 02.07.1. | B |
| 29 | 100 | Tablette(n) | C07AG02 | 02.07.1. | B |
| 37 | 30 | Tablette(n) | C07AG02 | 02.07.1. | B |
| 45 | 100 | Tablette(n) | C07AG02 | 02.07.1. | B |
| 88 | 14 | Tablette(n) | C07AG02 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dilatrend 12 authorised in Switzerland?
Yes. Dilatrend 12 is authorised by Swissmedic under authorisation number 53162, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dilatrend 12 have?
Dilatrend 12 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dilatrend 12?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.